Literature DB >> 20150596

The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease.

George J Brewer1.   

Abstract

It is a pleasure and an honor to contribute a paper to a special issue of the Journal of the American College of Nutrition honoring Stanley Wallach and Pearl Small. In this brief review I advance the hypothesis that copper toxicity is the major cause of the epidemic of mild cognitive impairment and Alzheimer's disease engulfing our aging population. This epidemic is recent, exploding in the last 50-60 years. The disease was virtually unknown 100 years ago. And it involves only developed countries that use copper plumbing. Something in our environment associated with development is poisoning the minds of our aged. The epidemic is associated with the use of copper plumbing, and the taking of copper in multi-mineral supplements. Food copper (organic copper) is processed by the liver and is transported and sequestered in a safe manner. Inorganic copper, such as that in drinking water and copper supplements, largely bypasses the liver and enters the free copper pool of the blood directly. This copper is potentially toxic because it may penetrate the blood/brain barrier. I review a web of animal and human data that tightens the noose around the hypothesis that copper toxicity is causing the epidemic of Alzeimer's disease and loss of cognition in our aging population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20150596     DOI: 10.1080/07315724.2009.10719777

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  14 in total

1.  Effect of heavy metals on silencing of engineered long interspersed element-1 retrotransposon in nondividing neuroblastoma cell line.

Authors:  Laleh Habibi; Mohammad Ali Shokrgozar; Mahdieh Motamedi; Seyed Mohammad Akrami
Journal:  Iran Biomed J       Date:  2013

2.  Crystal structure and Hirshfeld surface analysis of a copper(II) complex containing 2-nitro-benzoate and tetra-methyl-ethylenedi-amine ligands.

Authors:  Sevgi Kansiz; Adnan M Qadir; Necmi Dege; Li Yongxin; Eiad Saif
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-03-19

3.  Biocompatibility Assessment of Novel Bioresorbable Alloys Mg-Zn-Se and Mg-Zn-Cu for Endovascular Applications: In- Vitro Studies.

Authors:  Dharam Persaud-Sharma; Noah Budiansky; Anthony J McGoron
Journal:  J Biomim Biomater Tissue Eng       Date:  2013

4.  Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.

Authors:  Itender Singh; Abhay P Sagare; Mireia Coma; David Perlmutter; Robert Gelein; Robert D Bell; Richard J Deane; Elaine Zhong; Margaret Parisi; Joseph Ciszewski; R Tristan Kasper; Rashid Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 5.  Environmental factors in the development and progression of late-onset Alzheimer's disease.

Authors:  Moses N Wainaina; Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

6.  Excessive copper in feed not merely undermines animal health but affects food safety.

Authors:  Zicheng Ma; Yan Li; Zifeng Han; Zhaohu Liu; Hongyu Wang; Fanliang Meng; Sidang Liu; Dawei Chen; Mengda Liu
Journal:  J Vet Sci       Date:  2021-03-17       Impact factor: 1.672

7.  Copper and its complexes in medicine: a biochemical approach.

Authors:  Isidoros Iakovidis; Ioannis Delimaris; Stylianos M Piperakis
Journal:  Mol Biol Int       Date:  2011-06-15

8.  Multipath colourimetric assay for copper(II) ions utilizing MarR functionalized gold nanoparticles.

Authors:  Yulong Wang; Limin Wang; Zhenhe Su; Juanjuan Xue; Jinbo Dong; Cunzheng Zhang; Xiude Hua; Minghua Wang; Fengquan Liu
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

9.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

Review 10.  Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease.

Authors:  George J Brewer; Sukhvir Kaur
Journal:  Int J Alzheimers Dis       Date:  2013-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.